Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1860 1
1871 1
1874 1
1887 1
1895 1
1916 1
1922 1
1923 1
1926 1
1927 1
1935 2
1940 2
1941 1
1945 1
1946 11
1947 6
1948 8
1949 10
1950 8
1951 9
1952 14
1953 17
1954 12
1955 24
1956 17
1957 17
1958 16
1959 17
1960 24
1961 33
1962 35
1963 33
1964 36
1965 30
1966 29
1967 32
1968 37
1969 26
1970 48
1971 35
1972 40
1973 43
1974 60
1975 62
1976 67
1977 63
1978 53
1979 75
1980 85
1981 64
1982 92
1983 78
1984 89
1985 118
1986 127
1987 128
1988 134
1989 150
1990 145
1991 149
1992 179
1993 204
1994 183
1995 178
1996 198
1997 177
1998 196
1999 201
2000 246
2001 222
2002 191
2003 218
2004 256
2005 262
2006 270
2007 251
2008 285
2009 299
2010 365
2011 325
2012 354
2013 409
2014 445
2015 485
2016 456
2017 465
2018 470
2019 526
2020 641
2021 678
2022 647
2023 577
2024 486
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,675 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. Among authors: cohen ja. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Lublin FD, et al. Among authors: cohen ja. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28. Neurology. 2014. PMID: 24871874 Free PMC article.
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, Piskin D, Ravelli A, Sinha R, Aletaha D, Allen C, Bassiri H, Behrens EM, Carcillo J, Carl L, Chatham W, Cohen JI, Cron RQ, Drewniak E, Grom AA, Henderson LA, Horne A, Jordan MB, Nichols KE, Schulert G, Vastert S, Demirkaya E, Goldbach-Mansky R, de Benedetti F, Marsh RA, Canna SW; HLH/MAS task force. Shakoory B, et al. Among authors: cohen ji. Ann Rheum Dis. 2023 Oct;82(10):1271-1285. doi: 10.1136/ard-2023-224123. Epub 2023 Jul 24. Ann Rheum Dis. 2023. PMID: 37487610 Free PMC article.
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group. Bossuyt PM, et al. Among authors: cohen jf. BMJ. 2015 Oct 28;351:h5527. doi: 10.1136/bmj.h5527. BMJ. 2015. PMID: 26511519 Free PMC article.
Runners-up.
Pennisi E, Stokstad E, Gibbons A, Stone R, Cohen J, Savitsky Z, Voosen P, Hutson M, Kaiser J. Pennisi E, et al. Among authors: cohen j. Science. 2022 Dec 16;378(6625):1162-1167. doi: 10.1126/science.adg2799. Epub 2022 Dec 15. Science. 2022. PMID: 36520911 No abstract available.
Proteomic cardiovascular risk assessment in chronic kidney disease.
Deo R, Dubin RF, Ren Y, Murthy AC, Wang J, Zheng H, Zheng Z, Feldman H, Shou H, Coresh J, Grams M, Surapaneni AL, Bhat Z, Cohen JB, Rahman M, He J, Saraf SL, Go AS, Kimmel PL, Vasan RS, Segal MR, Li H, Ganz P. Deo R, et al. Among authors: cohen jb. Eur Heart J. 2023 Jun 20;44(23):2095-2110. doi: 10.1093/eurheartj/ehad115. Eur Heart J. 2023. PMID: 37014015 Free PMC article.
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, Piskin D, Ravelli A, Sinha R, Aletaha D, Allen C, Bassiri H, Behrens EM, Carcillo J, Carl L, Chatham W, Cohen JI, Cron RQ, Drewniak E, Grom AA, Henderson LA, Horne A, Jordan MB, Nichols KE, Schulert G, Vastert S, Demirkaya E, Goldbach-Mansky R, de Benedetti F, Marsh RA, Canna SW. Shakoory B, et al. Among authors: cohen ji. Arthritis Rheumatol. 2023 Oct;75(10):1714-1732. doi: 10.1002/art.42636. Epub 2023 Jul 24. Arthritis Rheumatol. 2023. PMID: 37486733 Free PMC article.
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
Huybrechts KF, Hernández-Díaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, Cohen JM, Panchaud A, Cohen L, Bateman BT. Huybrechts KF, et al. Among authors: cohen jm. JAMA Psychiatry. 2016 Sep 1;73(9):938-46. doi: 10.1001/jamapsychiatry.2016.1520. JAMA Psychiatry. 2016. PMID: 27540849 Free PMC article.
Pediatrics, Students, Allied Health and COVID-19.
Carey LB, Cohen J, Gabbay E, Koenig HG, Hill T, Aiken C, Drummond D, Carey JR. Carey LB, et al. Among authors: cohen j. J Relig Health. 2023 Apr;62(2):743-747. doi: 10.1007/s10943-023-01788-6. Epub 2023 Mar 4. J Relig Health. 2023. PMID: 36871100 Free PMC article.
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Slandzicki AJ, Lim SC, Cohen J, Kavtaradze D, Amon AP, Gabriel A, Gentile N, Felker GM, Jayaweera D, McCarthy MW, Sulkowski M, Rothman RL, Wilson S, DeLong A, Remaly A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Thicklin F, Hanna GJ, Ginde AA, Castro M, McTigue K, Shenkman E, Hernandez AF; Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Naggie S, et al. Among authors: cohen j. JAMA. 2023 Mar 21;329(11):888-897. doi: 10.1001/jama.2023.1650. JAMA. 2023. PMID: 36807465 Free PMC article.
12,675 results
You have reached the last available page of results. Please see the User Guide for more information.